Burzynski Research Institute, Inc.

General ticker "BZYR" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $5.8M (TTM average)

Burzynski Research Institute, Inc. follows the US Stock Market performance with the rate: 5.0%.

Estimated limits based on current volatility of -0.6%: low 0.04$, high 0.04$

Factors to consider:

  • Earnings expected soon, date: 2025-05-27 bmo
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-02-29 to 2026-02-28

  • 2024-02-29 to 2025-02-28 estimated range: [0.02$, 0.05$]
  • 2025-02-28 to 2026-02-28 estimated range: [0.02$, 0.05$]

Financial Metrics affecting the BZYR estimates:

  • Negative: Non-GAAP EPS, $ of -0.01 <= 0.04
  • Negative: Operating cash flow per share per price, % of -12.18 <= 1.79
  • Negative: negative Net income
  • Negative: Shareholder equity ratio, % of -1081.42 <= 22.52
  • Negative: negative Operating income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -25.63 <= 2.82
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term BZYR quotes

Long-term BZYR plot with estimates

Financial data

YTD 2022-02-28 2023-02-28 2024-02-29
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $0.98MM $0.92MM $1.34MM
Operating Income $-0.98MM $-0.92MM $-1.34MM
R&D Expense $0.76MM $0.72MM $0.86MM
Income(Loss) $-0.98MM $-0.92MM $-1.34MM
Profit(Loss)* $-0.98MM $-0.92MM $-1.34MM
Stockholders Equity $0.00MM $-0.01MM $-0.03MM
Assets $0.00MM $0.00MM $0.00MM
Operating Cash Flow $-0.33MM $-0.25MM $-0.52MM
Financing Cash Flow $0.33MM $0.25MM $0.52MM
Earnings Per Share** $-0.01 $-0.01 $-0.01

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.